235 related articles for article (PubMed ID: 10201088)
1. Perinatal outcome in pregnancies with a positive serum screening for Down's syndrome due to elevated levels of free beta-human chorionic gonadotropin.
Palacio M; Jauniaux E; Kingdom J; Dell E; Sheldrake A; Rodeck CH
Ultrasound Obstet Gynecol; 1999 Jan; 13(1):58-62. PubMed ID: 10201088
[TBL] [Abstract][Full Text] [Related]
2. Prediction of pregnancy complications by first-trimester maternal serum PAPP-A and free beta-hCG and with second-trimester uterine artery Doppler.
Spencer K; Yu CK; Cowans NJ; Otigbah C; Nicolaides KH
Prenat Diagn; 2005 Oct; 25(10):949-53. PubMed ID: 16086443
[TBL] [Abstract][Full Text] [Related]
3. Uterine artery Doppler velocimetry for the detection of adverse obstetric outcomes in patients with elevated mid-trimester beta-human chorionic gonadotrophin.
Barkehall-Thomas A; Wilson C; Baker L; ni Bhuinneain M; Wallace EM
Acta Obstet Gynecol Scand; 2005 Aug; 84(8):743-7. PubMed ID: 16026398
[TBL] [Abstract][Full Text] [Related]
4. Prediction of pre-eclampsia by uterine artery Doppler ultrasonography and maternal serum pregnancy-associated plasma protein-A, free beta-human chorionic gonadotropin, activin A and inhibin A at 22 + 0 to 24 + 6 weeks' gestation.
Spencer K; Yu CK; Savvidou M; Papageorghiou AT; Nicolaides KH
Ultrasound Obstet Gynecol; 2006 Jun; 27(6):658-63. PubMed ID: 16493628
[TBL] [Abstract][Full Text] [Related]
5. First trimester maternal serum screening for Down's syndrome: an evaluation of the DPC Immulite 2000 free beta-hCG and pregnancy-associated plasma protein-A assays.
Spencer K
Ann Clin Biochem; 2005 Jan; 42(Pt 1):30-40. PubMed ID: 15802030
[TBL] [Abstract][Full Text] [Related]
6. Correlation between first-trimester uterine artery Doppler indices and maternal serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein A.
Prefumo F; Canini S; Casagrande V; Pastorino D; Venturini PL; De Biasio P
Fertil Steril; 2006 Oct; 86(4):977-80. PubMed ID: 16963045
[TBL] [Abstract][Full Text] [Related]
7. Mid-trimester placentation assessment in high-risk pregnancies using maternal serum screening and uterine artery Doppler.
Hershkovitz R; de Swiet M; Kingdom J
Hypertens Pregnancy; 2005; 24(3):273-80. PubMed ID: 16263599
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Down's syndrome screening strategies in Asians combining serum free beta-hCG and alpha-fetoprotein with maternal age.
Hsu JJ; Hsieh TT; Soong YK; Spencer K
Prenat Diagn; 1997 Aug; 17(8):707-16. PubMed ID: 9267893
[TBL] [Abstract][Full Text] [Related]
9. [Correlation of free fetal DNA with beta-human chorionin gonadotropin in circulation in pregnant women with high risk of Down's syndrome].
Meng JL; Wang XT; Chen ZJ
Zhonghua Fu Chan Ke Za Zhi; 2009 Sep; 44(9):661-4. PubMed ID: 20079176
[TBL] [Abstract][Full Text] [Related]
10. The clinical value of combining maternal serum screening and uterine artery Doppler in prediction of adverse pregnancy outcome.
Elsandabesee D; Srinivas M; Kodakkattil S
J Obstet Gynaecol; 2006 Feb; 26(2):115-7. PubMed ID: 16483965
[TBL] [Abstract][Full Text] [Related]
11. Screening of maternal serum for fetal Down's syndrome in the first trimester.
Haddow JE; Palomaki GE; Knight GJ; Williams J; Miller WA; Johnson A
N Engl J Med; 1998 Apr; 338(14):955-61. PubMed ID: 9521983
[TBL] [Abstract][Full Text] [Related]
12. Pregnancy outcomes in unselected singleton pregnant women with an increased risk of first-trimester Down's syndrome.
Liu SS; Lee FK; Lee JL; Tsai MS; Cheong ML; She BQ; Chen SC
Acta Obstet Gynecol Scand; 2004 Dec; 83(12):1130-4. PubMed ID: 15548144
[TBL] [Abstract][Full Text] [Related]
13. If nuchal translucency screening is combined with first-trimester serum screening the need for fetal karyotyping decreases.
Marsk A; Grunewald C; Saltvedt S; Valentin L; Almström H
Acta Obstet Gynecol Scand; 2006; 85(5):534-8. PubMed ID: 16752230
[TBL] [Abstract][Full Text] [Related]
14. The role of second trimester uterine artery Doppler in predicting obstetric and neonatal outcomes in abnormal first trimester maternal serum pregnancy-associated plasma protein-A and free β-human chorionic gonadotropin values.
Dal Y; Akkuş F; Karagün Ş; Nessar AZ; Karaca SG; Coşkun A
J Clin Ultrasound; 2024 May; 52(4):394-404. PubMed ID: 38353146
[TBL] [Abstract][Full Text] [Related]
15. Ultrasound detection of placental insufficiency in women with elevated second trimester serum alpha-fetoprotein or human chorionic gonadotropin.
Toal M; Chaddha V; Windrim R; Kingdom J
J Obstet Gynaecol Can; 2008 Mar; 30(3):198-206. PubMed ID: 18364097
[TBL] [Abstract][Full Text] [Related]
16. Urine free beta hCG and beta core in pregnancies affected by Down's syndrome.
Spencer K; Aitken DA; Macri JN; Buchanan PD
Prenat Diagn; 1996 Jul; 16(7):605-13. PubMed ID: 8843469
[TBL] [Abstract][Full Text] [Related]
17. [Second trimester maternal serum screening for Down's syndrome in women of advanced maternal age: a multi-center prospective study].
Qi QW; Jiang YL; Liu JT; Bian XM; Li Y; Lü SM; Zhu BS; Wang H; Xu ZF; Pan XY; Cai Y
Zhonghua Fu Chan Ke Za Zhi; 2008 Oct; 43(10):737-41. PubMed ID: 19087538
[TBL] [Abstract][Full Text] [Related]
18. Serum markers for Down's syndrome in relation to number of previous births and maternal age.
Wald NJ; Watt HC
Prenat Diagn; 1996 Aug; 16(8):699-703. PubMed ID: 8878278
[TBL] [Abstract][Full Text] [Related]
19. Maternal serum screening for Down syndrome in a teaching hospital in Hong Kong.
Law L; Lau T; Fung T; Rogers MS; Hjelm M
Chin Med J (Engl); 1999 Aug; 112(8):754-7. PubMed ID: 11601289
[TBL] [Abstract][Full Text] [Related]
20. [Second trimester maternal serum screening for Down's syndrome in mainland China: a multi-center prospective study].
Bian XM; Liu JT; Qi QW; Jiang YL; Li Y; Liu SY; Hao N; Zhou J; Lü SM; Zhu BS; Wang H; Xu ZF; Pan XY; Liao C; Cai Y; Wang H; Wang Z; Zhu J; Hu YL
Zhonghua Fu Chan Ke Za Zhi; 2008 Nov; 43(11):805-9. PubMed ID: 19087560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
